Newborn screening for Duchenne muscular dystrophy: A two-year pilot study.

Annals of clinical and translational neurology(2023)

引用 2|浏览7
暂无评分
摘要
This study demonstrated that the state NBS program infrastructure and screening technologies we used are feasible to perform NBS for DMD. With an increasing number of treatment options, the clinical utility of early identification for affected newborns and their families lends support for NBS for this severe disease.
更多
查看译文
关键词
muscular dystrophy,newborn,screening,duchenne
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要